Abstract
Chronic soft tissue wound infections due to multidrug-resistant bacteria are a clinical challenge. Methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus spp. (VRE), aminoglycoside-resistant Escherichia coli and Pseudomonas aeruginosa are examples of several problematic pathogens. A multipronged clinical approach is necessary for resolution of these chronic infections and a good medical outcome.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
